---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-24-000095"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2024-07-30T23:59:59+00:00"
generated_at: "2026-05-31T15:28:48.141566+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Stryker Q2 2024: organic sales +9.0%, adj. EPS $2.81, raises FY guidance

## Summary
- Net sales $5.4B (+8.5% reported, +9.0% organic); MedSurg Neuro +9.7% organic, Ortho Spine +8.0% organic.
- Reported EPS $2.14 (+10.9% YoY); adjusted EPS $2.81 (+10.6% YoY); adjusted op. margin 24.6% (+30 bps).
- FY 2024 organic sales growth guidance raised to 9.0%-10.0%; adjusted EPS guidance $11.90-$12.10.
- Adjusted net earnings $1,085M (+11.2%). Guided for modest FX headwind ($0.10-$0.15) on adjusted EPS.

## SEC filing metadata
- accession: 0000310764-24-000095
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2024-07-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076424000095/0000310764-24-000095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076424000095/syk-20240730.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-24-000095
- JSON: https://secwatch.observer/filing/0000310764-24-000095.json
- Plain text: https://secwatch.observer/filing/0000310764-24-000095.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.